Plasticity of histamine H3 receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat.

Publisher: BioMed Central Country of Publication: England NLM ID: 100966986 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2202 (Electronic) Linking ISSN: 14712202 NLM ISO Abbreviation: BMC Neurosci Subsets: MEDLINE

Original Publication: London: BioMed Central, [2000-

Ear, Inner/*surgery ; Neuronal Plasticity/*physiology ; Receptors, Histamine H3/*physiology ; Vestibular Nuclei/*chemistry ; Vestibular Nuclei/*metabolism; Animals ; Autoradiography/methods ; Binding Sites/physiology ; Imidazoles/metabolism ; Iodine Radioisotopes/metabolism ; Male ; Protein Isoforms/physiology ; Rats ; Rats, Sprague-Dawley ; Vestibular Nuclei/surgery

Background: In rat, deafferentation of one labyrinth (unilateral labyrinthectomy) results in a characteristic syndrome of ocular and motor postural disorders (e.g., barrel rotation, circling behavior, and spontaneous nystagmus). Behavioral recovery (e.g., diminished symptoms), encompassing 1 week after unilateral labyrinthectomy, has been termed vestibular compensation. Evidence suggesting that the histamine H3 receptor plays a key role in vestibular compensation comes from studies indicating that betahistine, a histamine-like drug that acts as both a partial histamine H1 receptor agonist and an H3 receptor antagonist, can accelerate the process of vestibular compensation.
Results: Expression levels for histamine H3 receptor (total) as well as three isoforms which display variable lengths of the third intracellular loop of the receptor were analyzed using in situ hybridization on brain sections containing the rat medial vestibular nucleus after unilateral labyrinthectomy. We compared these expression levels to H3 receptor binding densities. Total H3 receptor mRNA levels (detected by oligo probe H3X) as well as mRNA levels of the three receptor isoforms studied (detected by oligo probes H3A, H3B, and H3C) showed a pattern of increase, which was bilaterally significant at 24 h post-lesion for both H3X and H3C, followed by significant bilateral decreases in medial vestibular nuclei occurring 48 h (H3X and H3B) and 1 week post-lesion (H3A, H3B, and H3C). Expression levels of H3B was an exception to the forementioned pattern with significant decreases already detected at 24 h post-lesion. Coinciding with the decreasing trends in H3 receptor mRNA levels was an observed increase in H3 receptor binding densities occurring in the ipsilateral medial vestibular nuclei 48 h post-lesion.
Conclusion: Progressive recovery of the resting discharge of the deafferentated medial vestibular nuclei neurons results in functional restoration of the static postural and occulomotor deficits, usually occurring within a time frame of 48 hours in rats. Our data suggests that the H3 receptor may be an essential part of pre-synaptic mechanisms required for reestablishing resting activities 48 h after unilateral labyrinthectomy.

J Neurophysiol. 1995 Nov;74(5):2087-99. (PMID: 8592199)
Exp Brain Res. 1995;105(1):18-24. (PMID: 7589314)
Neuroreport. 1997 Jul 28;8(11):2595-9. (PMID: 9261834)
Pharmacol Rev. 1997 Sep;49(3):253-78. (PMID: 9311023)
Eur J Neurosci. 1997 Oct;9(10):2019-34. (PMID: 9421163)
Eur J Neurosci. 1998 Jul;10(7):2287-301. (PMID: 9749757)
Neuroscience. 1998 Dec;87(4):797-805. (PMID: 9759967)
Brain Res. 1998 Sep 7;804(2):253-65. (PMID: 9757058)
Methods Find Exp Clin Pharmacol. 1998 Nov;20(9):771-7. (PMID: 10022031)
J Physiol. 1999 Mar 15;515 ( Pt 3):777-86. (PMID: 10066904)
Acta Otolaryngol Suppl. 1998;539:19-27. (PMID: 10095856)
Mol Pharmacol. 1999 Jun;55(6):1101-7. (PMID: 10347254)
Neuroscience. 1999;94(1):1-5. (PMID: 10613489)
Neuroreport. 2000 Mar 20;11(4):755-9. (PMID: 10757514)
J Pharmacol Exp Ther. 2000 Jun;293(3):771-8. (PMID: 10869375)
Acta Otolaryngol Suppl. 2000;544:15-8. (PMID: 10904796)
Mol Pharmacol. 2001 Jan;59(1):1-8. (PMID: 11125017)
Nature. 2000 Dec 14;408(6814):860-4. (PMID: 11130725)
Biochem Biophys Res Commun. 2001 Jan 12;280(1):75-80. (PMID: 11162480)
Prog Neurobiol. 2001 Apr;63(6):637-72. (PMID: 11164999)
Biochem J. 2001 Apr 15;355(Pt 2):279-88. (PMID: 11284713)
J Neural Transm (Vienna). 2002 Apr;109(4):443-53. (PMID: 11956964)
Neuroscience. 2002;111(1):189-206. (PMID: 11955722)
Neuropharmacology. 2002 Jun;42(7):929-40. (PMID: 12069903)
Eur J Pharmacol. 2002 Jun 20;446(1-3):63-73. (PMID: 12098586)
Neuroscience. 2002;114(1):173-93. (PMID: 12207964)
Eur J Pharmacol. 2003 Apr 25;467(1-3):57-65. (PMID: 12706455)
Eur J Pharmacol. 2003 Dec 15;482(1-3):49-60. (PMID: 14660004)
Acta Otolaryngol. 1973 Oct;76(4):229-38. (PMID: 4542914)
Nature. 1983 Apr 28;302(5911):832-7. (PMID: 6188956)
J Neurophysiol. 1984 Feb;51(2):242-59. (PMID: 6707721)
Brain Res. 1984 Mar 12;295(1):13-25. (PMID: 6713171)
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6. (PMID: 6371818)
Eur J Pharmacol. 1985 Apr 23;111(1):73-84. (PMID: 2990946)
Neuroscience. 1987 Oct;23(1):149-57. (PMID: 2446202)
Neuroscience. 1989;28(3):585-610. (PMID: 2710333)
Brain Res Brain Res Rev. 1989 Apr-Jun;14(2):155-80. (PMID: 2665890)
Neurosci Lett. 1990 Feb 16;109(3):287-92. (PMID: 2139500)
Exp Brain Res. 1991;84(2):417-25. (PMID: 2065749)
Exp Brain Res. 1991;84(2):426-33. (PMID: 1648506)
Acta Otolaryngol Suppl. 1991;479:12-23. (PMID: 2068936)
Acta Otolaryngol Suppl. 1991;479:5-11. (PMID: 2068941)
Mol Neurobiol. 1991;5(2-4):355-68. (PMID: 1668392)
Neuroreport. 1992 Oct;3(10):829-32. (PMID: 1421082)
Histochemistry. 1992 Aug;98(1):39-49. (PMID: 1429016)
Neuroscience. 1993 Jan;52(1):169-89. (PMID: 8381924)
Exp Brain Res. 1993;93(2):242-8. (PMID: 8387929)
Exp Brain Res. 1993;93(2):249-58. (PMID: 8491265)
Fundam Clin Pharmacol. 1994;8(2):128-37. (PMID: 8020871)
J Pharmacol Exp Ther. 1994 Oct;271(1):452-9. (PMID: 7965746)
Brain Res Brain Res Rev. 1995 Jan;20(1):24-46. (PMID: 7711766)
J Vestib Res. 1995 Jan-Feb;5(1):53-66. (PMID: 7711948)
Neuroscience. 1996 Jan;70(2):515-46. (PMID: 8848156)

0 (Imidazoles)
0 (Iodine Radioisotopes)
0 (Protein Isoforms)
0 (Receptors, Histamine H3)
0 (proxyfan)

Date Created: 20040914 Date Completed: 20050613 Latest Revision: 20181113

20221213

PMC517932

10.1186/1471-2202-5-32

15361262